Preventing costly delays in clinical trials via real-time shipment tracking
This white paper highlights how real-time monitoring is transforming the clinical supply chain. With 80% of trials delayed by at least a month, real-time tracking reduces costly delays, improves patient safety, and ensures timely delivery of IMPs. This shift minimizes temperature excursions, automates reporting, and enhances transparency, allowing pharmaceutical companies to meet trial deadlines and recruitment goals more effectively. Real-time monitoring is now essential for accelerating drug development and improving trial outcomes.
Pharma logistics
If you're involved in clinical trials, you know that delays can be costly—both in terms of patient health and market opportunities. With 80% of clinical trials delayed by at least a month, real-time shipment tracking offers a critical solution to keep trials on track.
By switching from passive to real-time monitoring, you can drastically reduce temperature excursions, automate reporting, and gain full visibility into your investigational medicinal products (IMPs). This not only prevents costly delays but also safeguards patient safety, enhances recruitment, and keeps your clinical trial moving forward efficiently.
Read this white paper to gain valuable insights into the future of clinical trial supply chains, and to learn how game-changing tracking technology can transform your trial logistics.
Download this white paper on the impact of real-time monitoring in the clinical trial supply chain
In clinical trials, delays can be costly—both in terms of patient health and market opportunities. This white paper explores how real-time shipment tracking is a game changer in preventing delays and transforming clinical trial logistics.
